BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38520490)

  • 1. Suppression of planktonic and biofilm of Escherichia coli by the synergistic lantibiotics-polymyxins combinations.
    Polyudova T; Lemkina L; Eroshenko D; Esaev A
    Arch Microbiol; 2024 Mar; 206(4):191. PubMed ID: 38520490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
    Chi H; Holo H
    Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.
    Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S
    J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.
    Draper LA; Cotter PD; Hill C; Ross RP
    BMC Microbiol; 2013 Sep; 13():212. PubMed ID: 24069959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli.
    Naghmouchi K; Belguesmia Y; Baah J; Teather R; Drider D
    Res Microbiol; 2011; 162(2):99-107. PubMed ID: 20868743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antibacterial and anti-biofilm activities of resveratrol and polymyxin B against multidrug-resistant Pseudomonas aeruginosa.
    Qi L; Liang R; Duan J; Song S; Pan Y; Liu H; Zhu M; Li L
    J Antibiot (Tokyo); 2022 Oct; 75(10):567-575. PubMed ID: 35999263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
    Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
    Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA.
    van der Linden DS; Short D; Dittmann A; Yu PL
    Biotechnol Lett; 2009 Aug; 31(8):1265-7. PubMed ID: 19396584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide.
    Viljanen P; Vaara M
    Antimicrob Agents Chemother; 1984 Jun; 25(6):701-5. PubMed ID: 6331296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Colistin and Bacteriocins Combinations on the In Vitro Growth of Escherichia coli Strains from Swine Origin.
    Al Atya AK; Abriouel H; Kempf I; Jouy E; Auclair E; Vachée A; Drider D
    Probiotics Antimicrob Proteins; 2016 Dec; 8(4):183-190. PubMed ID: 27557837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
    Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm.
    Okuda K; Zendo T; Sugimoto S; Iwase T; Tajima A; Yamada S; Sonomoto K; Mizunoe Y
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5572-9. PubMed ID: 23979748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the interaction between polymyxin B and Pseudomonas aeruginosa biofilm and planktonic cells: reactive oxygen species induction and zeta potential.
    Lima MR; Ferreira GF; Nunes Neto WR; Monteiro JM; Santos ÁRC; Tavares PB; Denadai ÂML; Bomfim MRQ; Dos Santos VL; Marques SG; de Souza Monteiro A
    BMC Microbiol; 2019 May; 19(1):115. PubMed ID: 31142260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
    Li Q; Montalban-Lopez M; Kuipers OP
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sucrose-induced osmotic stress on the sensitivity of
    Polyudova T; Eroshenko D; Korobov V
    Can J Microbiol; 2019 Dec; 65(12):895-903. PubMed ID: 31479619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.